Karen K Langdon, PA-C | |
2196 E Williams Field Rd Ste 116, Gilbert, AZ 85295-0755 | |
(480) 237-1395 | |
(602) 218-4076 |
Full Name | Karen K Langdon |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 2196 E Williams Field Rd Ste 116, Gilbert, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811094691 | NPI | - | NPPES |
900100 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 5505 (Arizona) | Secondary |
363A00000X | Physician Assistant | 5505 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Karen K Langdon, PA-C 130 Sutter St Fl 2, San Francisco, CA 94104-4009 Ph: (415) 658-6791 | Karen K Langdon, PA-C 2196 E Williams Field Rd Ste 116, Gilbert, AZ 85295-0755 Ph: (480) 237-1395 |
News Archive
Data from the PrimoTinA-asthma Phase III studies presented for the first time today at the 2012 European Respiratory Society (ERS) congress show that tiotropium significantly reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICSB/LABAC.
University of California, Irvine researchers will lead an unprecedented national effort to document the intricate cell types and states in breast tissue that underlie cancer.
A substantial number of premature infants born before 27 weeks gestational age encounter complicated medical problems. Although the survival rate of these infants has increased over the last two decades, the survival data for these patients is highly variable.
Results from two Phase 1 studies of ZOLINZA (vorinostat), Merck's oral histone deacetylase (HDAC) inhibitor, administered in combination with bortezomib, showed early anti-tumor activity in patients with relapsed and/or refractory multiple myeloma, including those previously treated with and no longer responding to bortezomib.
› Verified 2 days ago